Evidence map›Paper›PMID 31805664›Full record

ArticleCancers2019

Proteogenomics of Colorectal Cancer Liver Metastases: Complementing Precision Oncology with Phenotypic Data.

Bernhard Blank-Landeshammer, Vincent R Richard, Georgia Mitsa, Maud Marques, André LeBlanc, Laxmikanth Kollipara, Ingo Feldmann, Mathilde Couetoux du Tertre, Karen Gambaro, Suzan McNamara and 5 more

Abstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. STRIPAK, a fundamental signaling hub of eukaryotic development.Microbiology and molecular biology reviews : MMBR · 2024
    Review
  3. Review
  4. Review
  5. Article
  6. Proteomic Profiling and Biomarker Discovery in Colorectal Liver Metastases.International journal of molecular sciences · 2022
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Bernhard Blank-LandeshammerLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany.
Vincent R RichardSegal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.
Georgia MitsaSegal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.
Maud MarquesExactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada.
André LeBlancSegal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.
Laxmikanth KolliparaLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany.
Ingo FeldmannLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany.
Mathilde Couetoux du TertreExactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada.
Karen GambaroExactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada.
Suzan McNamaraExactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada.
Alan SpatzSegal Cancer Centre, Lady Davis Institute, Jewish General Hospital, and McGill University, Montreal, QC H4A3T2, Canada.
René P ZahediSegal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.
Albert SickmannLeibniz-Institut für Analytische Wissenschaften-ISAS-e.V., Otto-Hahn-Str. 6b, 44227 Dortmund, Germany.
Gerald BatistExactis Innovation, 5450 Cote-des-Neiges, Suite 522, Montreal, QC H3T1Y6, Canada.
Christoph H BorchersSegal Cancer Proteomics Centre, Lady Davis Institute, Jewish General Hospital, McGill University, Montreal, QC H3T1E2, Canada.

Funding

Genome Canada 264PROGenome Canada and Genome British Columbia 234DMP-DIG, 204PRO for operations, 214PRO for technology developmentMinisterium für Innovation, Wissenschaft und Forschung des Landes Nordrhein-Westfalen, the Senatsverwaltung für Wirtschaft, Technologie und Forschung des Landes Berlin, the Bundesministerium für Bildung und Forschung -Segal McGill Chair in Molecular Oncology at McGill University -Warren Y. Soper Charitable Trust and the Alvin Segal Family Foundation to the Jewish General Hospital -Warren Y. Soper Charitable Trust and the Alvin Segal Family Foundation to the Jewish General Hospital NCT00984048
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

absolute quantitationKRASmutation ratesPRMproteogenomicstargeted mass spectrometry

Identifiers

PMID31805664
PMCPMC6966481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.